Pharmacy Technology

WHAT IT MEANS AND WHY IT'S IMPORTANT The dramatic rise in the prevalence of diabetes over the next several decades is likely to place huge strains on the U.S. healthcare system, costing the country hundreds of billions of dollars every year. It also means the diabetes market will continue to be a hot bed for innovation for decades to come.

(THE NEWS: Diabetes prevalence among Americans may increase to 33%, CDC study finds. For the full story, click here)

ATLANTA The rate of diabetes among Americans is on an upswing and likely will reach epic proportions by 2050, costing the government millions.

NEW YORK In response to a national survey, which found that many women often are disappointed with their purchase of household products and desire more product innovation, Procter & Gamble has developed the multipronged “Have You Tried This Yet?” campaign as a way to highlight the manufacturer’s newer, more unique products. As part of the campaign, P&G opened to the public on Oct. 22 an interactive pop-up store in New York to drive awareness and product trials.

(Click here to view photos of P&G's New York pop-up store.)

SOUTH SAN FRANCISCO, Calif. The Food and Drug Administration has approved a biotech drug for treating cancer of the stomach and esophageal junction.

Genentech, a subsidiary of Swiss drug maker Roche, announced Wednesday the approval of Herceptin (trastuzumab) as a treatment for cancer of the stomach that includes the HER2 gene and has spread to other parts of the body, when combined with chemotherapy. The drug has long since had approval as a treatment for HER2-positive breast cancer.

MADISON, N.J. Multivitamin maker Centrum is encouraging women to pledge an hour toward an activity that is important to them.

BLOOMFIELD, Conn. Americans can lower their total medical costs significantly by taking simple steps to prevent or manage disease and by switching to generic drugs whenever possible, new research from health insurance giant Cigna confirmed.